Rosty Raykov Fennec Pharmaceuticals Inc. (FENC) insider trading activity

Rosty Raykov is of FENNEC PHARMACEUTICALS INC.. Currently has a direct ownership of 87,110 shares of FENC, which is worth approximately $716,044. The most recent transaction as insider was on Oct 08, 2025, when has been sold 4,609 shares (Common Shares) at a price of $2.45 per share, resulting in proceeds of $11,292. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.1K

32.23% 3M change

26.5% 12M change

Total Value Held $716,044

Rosty Raykov Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 08 2025	BUY Exercise of conversion of derivative security	$11,292 $2.45 p/Share	4,609 Added 5.03%	87,110 Common Shares
Oct 06 2025	SELL Open market or private sale	$97,800 $9.78 p/Share	10,000 Reduced 10.81%	82,501 Common Shares
Sep 30 2025	BUY Grant, award, or other acquisition	-	5,208 Added 5.33%	92,501 Common Shares
Sep 05 2025	BUY Exercise of conversion of derivative security	$88,707 $2.45 p/Share	36,207 Added 29.32%	87,293 Common Shares
Sep 04 2025	SELL Open market or private sale	$89,200 $8.92 p/Share	10,000 Reduced 16.37%	51,086 Common Shares
Aug 31 2025	BUY Grant, award, or other acquisition	-	5,208 Added 7.86%	61,086 Common Shares
Aug 05 2025	SELL Open market or private sale	$80,900 $8.09 p/Share	10,000 Reduced 15.18%	55,878 Common Shares
Jul 31 2025	BUY Grant, award, or other acquisition	-	5,208 Added 7.33%	65,878 Common Shares
Jul 03 2025	SELL Open market or private sale	$86,100 $8.61 p/Share	10,000 Reduced 14.15%	60,670 Common Shares
Jun 30 2025	BUY Grant, award, or other acquisition	-	5,208 Added 6.86%	70,670 Common Shares
Jun 05 2025	SELL Open market or private sale	$77,800 $7.78 p/Share	10,000 Reduced 13.25%	65,462 Common Shares
May 31 2025	BUY Grant, award, or other acquisition	-	5,208 Added 6.46%	75,462 Common Shares
May 16 2025	SELL Open market or private sale	$113,002 $6.78 p/Share	16,667 Reduced 19.17%	70,254 Common Shares
May 16 2025	BUY Grant, award, or other acquisition	-	33,334 Added 27.72%	86,921 Common Shares
May 05 2025	SELL Open market or private sale	$63,099 $6.31 p/Share	10,000 Reduced 15.73%	53,587 Common Shares
Apr 30 2025	BUY Grant, award, or other acquisition	-	2,431 Added 3.68%	63,587 Common Shares
Apr 04 2025	SELL Open market or private sale	$52,500 $5.25 p/Share	10,000 Reduced 14.05%	61,156 Common Shares
Mar 31 2025	BUY Grant, award, or other acquisition	-	2,431 Added 3.3%	71,156 Common Shares
Mar 05 2025	SELL Open market or private sale	$67,900 $6.79 p/Share	10,000 Reduced 12.7%	68,725 Common Shares
Feb 28 2025	BUY Grant, award, or other acquisition	-	2,431 Added 3.0%	78,725 Common Shares
Feb 05 2025	SELL Open market or private sale	$66,600 $6.66 p/Share	10,000 Reduced 11.59%	76,294 Common Shares
Jan 31 2025	BUY Grant, award, or other acquisition	-	2,431 Added 2.74%	86,294 Common Shares
Jan 06 2025	SELL Open market or private sale	$60,800 $6.08 p/Share	10,000 Reduced 10.65%	83,863 Common Shares
Dec 31 2024	BUY Grant, award, or other acquisition	-	2,431 Added 2.52%	93,863 Common Shares
Dec 20 2024	BUY Exercise of conversion of derivative security	$67,250 $2.69 p/Share	25,000 Added 21.47%	91,432 Common Shares

Rosty Raykov

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FENC shares.

Notify only if

Value

Insider Trading

Get notified when an Fennec Pharmaceuticals Inc. insider buys or sells FENC shares.

Notify only if

Operation

Value

Type

News

Receive news related to FENNEC PHARMACEUTICALS INC.

Track Activities on FENC

Account